EcoDrugPlus

Checkpoint Kinase 2

Ensembl ID : ENSNGAG00000011754
Gene Symbol: CHEK2
3 Cross references
204 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4

Ensembl ID : ENSNGAG00000002679
Gene Symbol: CXCR4
1 Cross references
283 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSNGAG00000021342
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSNGAG00000007686
Gene Symbol: CCKBR
3 Cross references
264 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSNGAG00000007986
Gene Symbol: LOC103727655
3 Cross references
259 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSNGAG00000002478
Gene Symbol: CETP
2 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSNGAG00000002773
Gene Symbol: CHRM1
3 Cross references
101 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSNGAG00000015929
Gene Symbol: CHRM2
3 Cross references
259 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSNGAG00000018133
Gene Symbol: CHRM3
3 Cross references
255 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSNGAG00000015741
Gene Symbol: CHRM4
3 Cross references
184 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSNGAG00000006622
Gene Symbol: CHRM5
3 Cross references
263 Possible Orthologues:

Cholinergic Receptor Nicotinic Alpha 3 Subunit

Ensembl ID : ENSNGAG00000008306
Gene Symbol: CHRNA3
3 Cross references
207 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).